Amamou A, Leboutte M, Breton J, Ribet D, Thiebaut P-A, Ble-Feysot C, et al
During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Uncontrolled hypertension or cardiac arrhythmias
Tendon and ligament injuries
It can be an attractive option for those seeking alternatives to or support around surgery, or for chronic or acute soft tissue issues